Okay, let me tackle this question. The user provided a question about prostate-specific antigen (PSA) and wants a detailed explanation. The correct answer isn't given, but I need to figure out which option is the exception. First, I should recall what PSA is.

PSA is a glycoprotein produced by the prostate gland, mainly by the epithelial cells. Its primary function is to liquefy semen by breaking down the clot formed after ejaculation. So, any statement contradicting this would be the correct answer.

The options are A to D, but they're not listed. However, common incorrect statements about PSA include things like it being a tumor marker for all prostate cancers, or that it's only elevated in prostate cancer. But wait, PSA can also be elevated in benign conditions like BPH or prostatitis. Also, PSA is a serine protease, not a glycoprotein? Wait, no, PSA is a glycoprotein. Another point is that PSA is used in screening, but it's not specific. So if an option says PSA is not elevated in prostate cancer, that's wrong. Or if it says PSA is used for screening but has no role in monitoring, that's incorrect.

The correct answer would be the one that's false. For example, if an option states that PSA is not a useful marker for prostate cancer, that's the exception. Alternatively, if an option claims that PSA is produced by the seminal vesicles instead of the prostate, that's wrong. Another possible wrong statement could be that PSA levels are not affected by factors like age or benign prostatic hyperplasia.

So, the core concept here is understanding PSA's role, production, and clinical use. The correct answer will be the statement that's not true about PSA. The other options might correctly state that PSA is a glycoprotein, a serine protease, used in screening, and elevated in prostate cancer. The exception could be that PSA is not elevated in all prostate cancers, or that it's specific to prostate cancer. Wait, but PSA is specific to the prostate, but not specific to cancer. So an option saying PSA is a specific tumor marker for prostate cancer would be incorrect because it can be elevated in benign conditions. That would be the exception.

**Core Concept**
Prostate-specific antigen (PSA) is a serine protease glycoprotein produced by prostate epithelial cells. It functions to liquefy seminal fluid post-ejaculation and serves as a biomarker for prostate pathology, including cancer. Clinical interpretation must consider benign conditions like BPH or prostatitis that can also elevate PSA.

**Why the Correct Answer is Right**
The correct answer is the statement that contradicts established PSA facts. For example, if an option claims PSA is *not* elevated in prostate cancer, this is false because PSA levels correlate with prostate cancer presence, though not exclusively (benign conditions can also elevate it). Alternatively, if an option states PSA is produced by seminal vesicles, this is incorrect as PSA is prostate-specific. The correct answer must align with these principles.

**Why Each Wrong Option is Incorrect**
**Option A:** If it states "PSA is a glycoprotein," this is correct. PSA is a glycoprotein secreted by prostate cells.
**Option B:** If it claims "PSA levels are not affected by BPH," this is incorrect because

✓ Correct Answer: A. Normal level is 10-14 ng/mL